Alzheimer Disease (AD) Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Alzheimer Disease (AD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Comprehensive Assessment of Neurodegeneration and Dementia

DementiaMild Cognitive Impairment (MCI)Subjective Cognitive Impairment+7 more
McGill University1,573 enrolled19 locationsNCT03402919
Recruiting
Phase 3

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

EpilepsyAlzheimer DiseaseSeizures+7 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau120 enrolled5 locationsNCT07234695
Recruiting
Phase 2

Daridorexant for Alzheimer Disease Prevention

Alzheimer Disease (AD)
Douglas Mental Health University Institute240 enrolled1 locationNCT07213349
Recruiting

Brain NAD in Alzheimer's Disease

Alzheimer Disease (AD)
Florida Atlantic University20 enrolled1 locationNCT07127510
Recruiting
Early Phase 1

Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease

Alzheimer Disease (AD)
Anhui Provincial Hospital30 enrolled1 locationNCT07208344
Recruiting
Not Applicable

Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study

Cognitive ImpairmentMild Cognitive Impairment (MCI)Alzheimer Disease (AD)+1 more
HudsonAlpha Institute for Biotechnology200 enrolled1 locationNCT07146412
Recruiting
Not Applicable

Alzheimer's Disease Treated With Vagus Nerve Stimulation

Alzheimer Disease (AD)
Beijing Municipal Administration of Hospitals74 enrolled1 locationNCT06923007
Recruiting
Not Applicable

Silkworm Pupa Powder Improves Dementia.

SarcopeniaAlzheimer Disease (AD)Asthenia
Zhejiang Provincial Tongde Hospital300 enrolled1 locationNCT06898476
Recruiting
Phase 1Phase 2

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

Amyotrophic Lateral Sclerosis(ALS)Alzheimer Disease (AD)Parkinson Disease (PD)+1 more
Ashvattha Therapeutics, Inc.65 enrolled3 locationsNCT05395624